Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Jun. 30, 2020
CURRENT ASSETS
Cash	$ 8,841	$ 15,282
Prepaid expenses and other assets	14,480	13,361
Tax refunds receivable	1,831	3,317
Accounts receivable, net	13,095	9,858
Note receivable, related party	2,385	6,878
Total Current Assets	40,632	48,696
Property and Equipment, Net	1,671	1,922
Operating lease right-of-use asset	78,868	74,710
TOTAL ASSETS	121,171	125,328
LIABILITIES
Accounts payable and accrued expenses	129,260	119,246
Accrued interest - related party	55,019	42,359
Notes payable - related party	739,550	618,568
Current portion of operating lease liability	16,615	11,312
Total Current Liabilities	940,444	791,485
Operating lease liability, net of current portion	62,956	63,721
Total Liabilities	1,003,400	855,206
STOCKHOLDERS' DEFICIT
Common stock, no par value; 250,000,000 shares authorized 203,355,598 and 203,355,598 shares issued and 203,301,842 and 203,301,842 shares outstanding respectively	33,027,676	33,027,676
Additional paid-in capital	4,513,328	4,513,328
Treasury stock, at cost	(19,387)	(19,387)
Accumulated other comprehensive income	90,741	91,907
Accumulated deficit	(37,845,201)	(37,696,425)
Total Sangui Biotech International, Inc's stockholders' defict	(232,843)	(82,901)
Non-controlling interest	(649,386)	(646,977)
Total Stockholders' Deficit	(882,229)	(729,878)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 121,171	$ 125,328